Date: October 04, 2022

Researchers at The University of Texas at El Paso’s School of Pharmacy are leading efforts to reduce mortality rates in lung, ovarian and pancreatic cancer with $3.8 million in funding from the National Institutes of Health (NIH).
Full story: [ Link to University Communications ]

